Article Details

REGENXBIO Presents Positive Initial Data from Phase II ALTITUDE™ Trial of RGX-314 for ...

Retrieved on: 2021-10-09 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

REGENXBIO Presents Positive Initial Data from Phase II ALTITUDE™ Trial of RGX-314 for .... View article details on hiswai:

Excerpt

Summary of Data for Cohort 1 at Three Months. Of the 15 patients dosed with RGX-314 in Cohort 1, five patients (33%) demonstrated a two-step or greater ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up